Related Experiment Video
Updated: May 4, 2026
16:49
Multifocal Electroretinograms
Published on: December 4, 2011
18.3K
Multifocal electroretinography after high dose chloroquine therapy for malaria
Aline Correa de Carvalho1, Martin Schwarz2, Givago da Silva Souza3
1Núcleo de Medicina Tropical, Universidade Federal do Pará, Belém, Pará, Brazil.
Journal of Ophthalmic & Vision Research
|December 19, 2013
Summary
High-dose chloroquine therapy for malaria in Brazil did not show retinal toxicity in mfERG tests. Retinal changes appear dependent on cumulative chloroquine dose, not malaria treatment intensity.
Area of Science:
- Ophthalmology
- Tropical Medicine
- Pharmacology
Background:
- Chloroquine is a key antimalarial drug.
- High-dose chloroquine use raises concerns about potential retinal toxicity.
- Understanding dose-dependent effects is crucial for patient safety.
Purpose of the Study:
- To evaluate multifocal electroretinography (mfERG) changes in patients treated for malaria with high-dose chloroquine.
- To assess the association between chloroquine cumulative dose and retinal function.
- To investigate potential retinal toxicity in a Brazilian Amazonia population.
Main Methods:
- mfERG parameters (amplitude, implicit time of N1, P1, N2 waves) were measured.
- Study included 48 patients treated for malaria and 37 healthy controls.
- Retinal responses were analyzed across different eccentricities.
Main Results:
- No significant differences in mfERG parameters were found between chloroquine-treated patients and controls.
- Retinal toxicity observed in prior studies correlated with higher cumulative chloroquine doses.
- Findings suggest retinal toxicity is linked to cumulative dose, not solely malaria treatment intensity.
Conclusions:
- Intensive high-dose chloroquine therapy for malaria in this cohort was not linked to mfERG-detectable retinal toxicity.
- Retinal safety of chloroquine appears to be dose-dependent.
- Further research may be warranted for specific cumulative dose thresholds.
